Journal articles on the topic 'Alexandre Jaba'

+ &nbsp; <em>N&ucirc;bar</em> &ucirc; <em>Eq&icirc;deya &Icirc;man&ecirc;</em> du berhem&ecirc;n gelek gir&icirc;ng in di prosesa perwerdeya klas&icirc;k de &ucirc; herwiha pişt&icirc; xwendina Qur&rsquo;an&ecirc; xwendina van herdu berheman di nav Kurdan de weku &ccedil;andeke berbelav t&ecirc; d&icirc;tin. Lewma pişt&icirc; tel&icirc;f&ecirc; gelek nusxey&ecirc;n van berheman di nav Kurdan de hatine &icirc;st&icirc;nsaxkirin. Destniv&icirc;s&ecirc;n ku di koleks&icirc;yona Kurd&icirc; ya Alexandre Jaba de bi nav&ecirc;n <em>Kurd 21</em>, <em>Kurd 22</em>, <em>Kurd 47</em> hatine tomarkirin, berhem&ecirc;n Ehmed&ecirc; Xan&icirc; y&ecirc;n bi nav&ecirc; <em>N&ucirc;bar</em> &ucirc; <em>Eq&icirc;deya &Icirc;man&ecirc;</em> ne. Me di v&ecirc; xebat&ecirc; de van destniv&icirc;s&ecirc;n navbor&icirc; nasandin &ucirc; anal&icirc;z kirin. Nasandina destniv&icirc;san bi du away&icirc;; ji al&icirc;y&ecirc; teşe &ucirc; naverok&ecirc; ve hatiye kirin. Ji h&ecirc;la teşey&ecirc; ve sernav, cins &ucirc; reng&ecirc; kaxiz&ecirc;, reng&ecirc; niv&icirc;s&ecirc;, kes&ecirc; ku destniv&icirc;s &icirc;stinsax kir&icirc; ango mustens&icirc;x, tar&icirc;xa destniv&icirc;s&ecirc;, r&ecirc;zik, sit&ucirc;n, reng&ecirc; murekeb&ecirc;, agah&icirc;y&ecirc;n li ser berg&ecirc; berhem&ecirc;, hecm &ucirc; xis&ucirc;s&icirc;yet&ecirc;n bi v&icirc; reng&icirc; hatin ravekirin. Ji h&ecirc;la naverok&ecirc; ve j&icirc; di nav mecmu&#39;eyan de k&icirc;jan berhem cih girtibin, mijar&ecirc;n wan, sernav &ucirc; beş&ecirc;n wan, j&ecirc;renot, pasaj&ecirc;n destp&ecirc;k &ucirc; d&ucirc;mah&icirc;ka wan hatin ravekirin. Ber&icirc; ku ev danas&icirc;n&ecirc;n tekn&icirc;k&icirc; b&ecirc;n kirin, weku destp&ecirc;k me di v&ecirc; xebat&ecirc; de qala Alexandre Jaba &ucirc; serp&ecirc;hat&icirc;ya w&icirc; ya tomarkirina van destniv&icirc;san kir. Herwiha pişt&icirc; ku daner&ecirc; van berheman; Ehmed&ecirc; Xan&icirc; hat nasandin, di bin sernavek&icirc; din de me derbar&ecirc; destniv&icirc;s &ucirc; &ccedil;ap&ecirc;n <em>N&ucirc;bara Bi&ccedil;&ucirc;kan</em> de y&ecirc;n ku ji ber&ecirc; ta niha hatine peydakirin &ucirc; z&ecirc;dekirin, hin agah&icirc; parve kirin. Her&icirc; daw&icirc; me van destniv&icirc;s&ecirc;n ku bi awayek&icirc; tekn&icirc;k&ecirc; hatin nasandin, ji h&ecirc;la ş&ecirc;waz &ucirc; tar&icirc;xa &icirc;stinsaxa wan, ji h&ecirc;la k&ecirc;mas&icirc; &ucirc; z&ecirc;deh&icirc;y&ecirc;n wan ve berawird kirin. Me hin manend&icirc; &ucirc; cudah&icirc;y&ecirc;n wan di encama v&ecirc; berawirdkirin&ecirc; de destn&icirc;şan kirin &ucirc; li gor&icirc; v&ecirc; yek&ecirc; me destniv&icirc;sa tek&ucirc;ztir &ucirc; ya b&ecirc;tir n&ecirc;z&icirc; ya resen, li gor&icirc; wan encaman d&icirc;yar kir.

Abstract Through sensitive engagement with the experimental films of Arthur Jafa, the flex choreography of Storyboard P, and performance of #BlackLivesMatter protests, this essay submits revenant motion as a concept through which to think about black being and phenomenology in this era. The entwined reflections on black life, death, and aesthetics offered up by Jafa, Claudia Rankine, Hortense Spillers, Elizabeth Alexander, and Sylvia Wynter shape these speculations toward a black creative, curatorial, and cultural practice attentive to the other(wise) worlds opened by uncanny reanimation. The suggestion here is that revenant motion might name a genre (à la Wynter) of the perennial danse macabre, which often figures Death dancing among the living as a reminder to too-worldly humans of its ever-presence and equalizing power. The creative and critical practices considered here also persistently foreground the melancholy possibilities and pleasures that our collective entanglements with black after/other/lives affords. This study of the macabre aesthetic as it manifests in latter-day memento mori sharpens our awareness of the proximity of horror and romance. In doing so it provides us with an occasion to think about how the gothic character of black life emerges in the sensual and sensorial performance of mourning and artful response to grief.

Cyril of Alexandria did not treat the problem of God’s transcendence and immanence as extensively and profoundly as did John Chrysostom, due to the fact that the question was not as relevant in Cyril’s time as is was in the time of Chrysostom. However, the ideas of the latter are present in the writings of Cyril, who draws a distinction between the inner being of God and His work. This simi­larity can be traced in two main points. First, God in His essential nature surpasses everything. This inner life of God is above and beyond any knowledge and reach, any concept and reasoning. All that we know about the nature of God is that He acts in the world and this action is performed by the Father through the Son in the Spirit. Second, in order to outline God’s action, Cyril uses the terms „power” and „energy” indistinguishably. For both authors the method of antinomy is a primary system of coordinates in which they combine the two fundamentally opposite poles of God’s being: the transcendent and the immanent. So, in this point the Oriental Theological Schools of Alexandria and Antioch are internally consonant.

The aims of this study were to investigate hearing aid satisfaction for a group of older Australians fitted with government-funded hearing aids using the Satisfaction with Amplification in Daily Life (SADL) questionnaire; to compare the Australian data gathered with the provisional normative data reported by Cox and Alexander (1999); and to investigate the relationship between SADL satisfaction and several participant variables, hearing aid variables, and other outcome measures.The SADL questionnaire and a Client Satisfaction Survey (CSS) were distributed by mail to 1284 adults fitted with government-funded hearing aids three to six months previously. 1014 surveys were returned. The mean age of participants was 75.32 years; 54.4% of participants were male, and 54.8% were fitted binaurally. Participants were fitted primarily with digitally programmable hearing aids of various styles (22.5% BTEs, 34.8% ITEs, 41.8% ITCs, 0.9% nonstandard [NS] devices).Overall, participants reported a considerable level of satisfaction with their devices. SADL Global and subscale scores were significantly higher for the Australian sample than the U.S. norms described by Cox and Alexander (1999).

The article is an analysis of the images of magic-wielding characters in Russian magic fairy tales. The basis of this analysis is a set of fairy tales collected by Alexander Afanasyev. The author focuses primarily on the characters of Baba Yaga and Koschei the Immortal, pointing in particular to the ambiguity of the former. She can be seen as a witch, a demon and deity, as an antagonist — just like other fairy tale witches — but also as a donor, tester, and catalyst of the protagonist’s evolution. In the case of Koschei, although he always turns out to be an antagonist, what deserves attention is the level of his power — much higher than in the case of “lower-order” sorcerers — and the motif of the seven-stage soul hiding as the source of immortality. Also considered is the image of dragons, characteristic of Slavic fairy tales — perceived in this cultural circle as chthonic beings, related to snakes and in opposition to birds, i.e. uranic beings. In the course of the analysis, the author also compares the images of magic-wielding characters in Afanasyev’s collection with those gathered by the Brothers Grimm.

Background: Cochlear implants (CI) have become widely used for the management of profound sensorineural hearing loss. However, data relative to satisfaction in CI users are not so readily available. No standard outcome inventory for CI users has been developed. The Satisfaction with Amplification in Daily Life (SADL) inventory was originally developed for hearing aid users by Cox and Alexander (1999). Because the SADL inventory has been shown to have good psychometric properties for use within hearing aid users, the present study adapted the SADL for CI use and assessed the validity and reliability of the adapted version. Purpose: (1) To explore the factor structure (i.e., subscales), validity, and reliability of the SADL inventory applied to CI users and compare the resulting factor structure to that reported by Cox and Alexander (1999) for hearing aid users; and (2) to evaluate the satisfaction level of CI users as measured by the SADL inventory and compare the satisfaction level of unilateral CI users (CI-only) to that of users of a CI and hearing aid in opposite ears (CIHA). Research Design: A cross-sectional survey. All CIHA users in this study voluntarily elected to wear their hearing aids in conjunction with their CIs. Study Sample: The satisfaction level of postlingually deafened adult CI users was assessed for 100 CI-only and 35 CIHA users using the SADL inventory. Data Collection And Analysis: The psychometric properties of the adapted SADL following administration to CI-only and CIHA users were examined through a factor analysis. Results: A similar factor structure was found for CI-only users compared to the original published SADL data. The differences were primarily related to one particular factor. CI users have a moderately high satisfaction level. No significant differences were found between the CI-only and CIHA groups except for hearing aid feedback. Conclusions: It is concluded that the SADL is appropriate for clinical use with CI users.

The effects of relative tendon/fiber proportion and tendon elasticity on the force output of the Hill muscle model (a contractile component [CC] in series with an elastic element [SEC]) were examined through computer simulation. Three versions of the Hill model were constructed. Model 1 examined the effect of relative tendon/fiber proportion on CC kinematics and kinetics during an isometric twitch, while Model 2 compared the effect of changes in tendon compliance. These models revealed force profile differences related to alterations in CC velocity, although the reasons underlying the variation in CC kinematics were different. The relative tendon/fiber proportion and tendon compliance differences were examined in combination in Model 3. Test simulations revealed response differences among the three model versions, and therefore verified Alexander and Ker's (1990) contention that the morphology of muscle is related to design criteria. It is suggested that the implementation of generalized muscle models to represent specific units of the musculoskeletal system should be done carefully and that the implementation process itself warrants further study.

Background: The recent introduction of digital hearing aid technology for bone-conduction devices employing percutaneous stimulation may be beneficial for patients with conductive and mixed hearing loss and single sided deafness. Purpose: Performance of a recently released sound processor for bone-anchored implants, the Ponto Pro Power from Oticon Medical (bone-conduction device 2 [BCD2]), was compared with that of the Baha Intenso from Cochlear (bone-conduction device 1 [BCD1]). Research Design: Direct comparison of the subject's own device (BCD1) with the new device (BCD2) was examined in a nonrandomized design. Subjects were initially tested with BCD1. BCD2 was tested after a 4 wk acclimatization period. Study Sample: Eighteen subjects with mixed hearing loss and with at least 4 mo experience with BCD1 completed the study. Mean air-conduction and bone-conduction thresholds averaged across the frequencies of 500, 1000, 2000, and 4000 Hz were 73.9 and 34.2 dB HL, respectively. Data Collection and Analysis: Performance of the two devices was evaluated objectively by measuring aided free-field thresholds, speech perception in quiet, and speech perception in noise. A subjective evaluation was carried out with the Abbreviated Profile of Hearing Aid Benefit (APHAB) (Cox and Alexander, 1995) and the Speech, Spatial and Qualities of Hearing Scale (SSQ) questionnaire (Gatehouse and Noble, 2004). In addition, user experiences, user satisfaction, and device preference were obtained via proprietary questionnaires. Statistical significance was established with analysis-of-variance (ANOVA) and paired t-statistics with Bonferroni correction. Results: Aided free-field thresholds and speech reception thresholds (SRTs) in quiet were not statistically significantly different for either device (p &gt; 0.05). In contrast, SRTs in noise were 2.0 dB lower (p &lt; 0.001) for BCD2 than for BCD1. APHAB questionnaire scores on all subscales provided statistically significantly greater benefit (p &lt; 0.05) for BCD2 than for BCD1. Also, with the SSQ most items in the speech and sound quality domain were significantly more favorable (p &lt; 0.05) for BCD2 than for BCD1. Finally, all subjects preferred BCD2 over BCD1 with 14 subjects reporting a strong preference and four subjects an average preference for the digital signal processing provided by BCD2 over previous technology provided by BCD1.

Background: Despite evidence suggesting inaccuracy in the default fittings provided by hearing aid manufacturers, the use of probe-microphone measures for the verification of fitting accuracy is routinely used by fewer than half of practicing audiologists. Purpose: The present study examined whether self-perception of hearing aid benefit, as measured through the Abbreviated Profile of Hearing Aid Benefit (APHAB; Cox and Alexander, 1995), differed as a function of hearing aid fitting method, specifically, manufacturer's initial-fit approach versus a verified prescription. The prescriptive fit began at NAL-NL1 targets, with adjustments based on participant request. Each of the two fittings included probe-microphone measurement. Research Design: A counterbalanced, cross-over, repeated-measures, single-blinded design was utilized to address the research objectives. Study Sample: Twenty-two experienced hearing aid users from the general Bay Pines VA Healthcare System audiology clinic population were randomized into one of two intervention groups. Intervention: At the first visit, half of the participants were fit with new hearing aids via the manufacturer's initial fit while the second half were fit to a verified prescription using probe-microphone measurement. After a wear period of 4–6 wk, the participants' hearing aids were refit via the alternate method and worn for an additional 4–6 wk. Participants were blinded to the method of fitting by utilizing probe-microphone measures with both approaches. Data Collection and Analysis: The APHAB was administered at baseline and at the end of each intervention trial. At the end of the second trial period, the participants were asked to identify which hearing aid fitting was “preferred.” The APHAB data were subjected to a general linear model repeated-measures analysis of variance. Results: For the three APHAB communication subscales (i.e., Ease of Communication, Reverberation, and Background Noise) mean scores obtained with the verified prescription were higher than those obtained with the initial-fit approach, indicating greater benefit with the former. The main effect of hearing aid fitting method was statistically significant [F (1, 21) = 4.69, p = 0.042] and accounted for 18% of the variance in the data (partial eta squared = 0.183). Although the mean benefit score for the APHAB Aversiveness subscale was also better (i.e., lower) for the verified prescription than the initial-fit approach, the difference was not statistically significant. Of the 22 participants, 7 preferred their hearing aids programmed to initial-fit settings and 15 preferred their hearing aids programmed to the verified prescription. Conclusions: The data support the conclusion that hearing aids fit to experienced hearing aid wearers using a verified prescription are more likely to yield better self-perceived benefit as measured by the APHAB than if fit using the manufacturer's initial-fit approach.

Coronary artery aneurysms (CAAs) are relatively rare defects that range significantly in clinical presentation, most often discovered in adults with concomitant coronary artery disease. There remains no general consensus on the optimal management of CAAs. A vast majority of cases reported in literature are managed operatively or with percutaneous stenting. We however demonstrate a case of a CAA discovered upon angiography for a STEMI managed entirely with intracoronary thrombolytics and intravenous heparin, followed by a repeat coronary angiography that confirmed re-opening of the occluded vessel now with distal coronary blood flow. 1. Matta AG, Yaacoub N, Nader V, Moussallem N, Carrie D, Roncalli J. Coronary artery aneurysm: A review. World J Cardiol. 2021 Sep 26;13(9):446-455. doi: 10.4330/wjc.v13.i9.446. PMID: 34621489; PMCID: PMC8462041. 1. Kawsara, A, Núñez Gil, I, Alqahtani, F. et al. Management of Coronary Artery Aneurysms. J Am Coll Cardiol Intv. 2018 Jul, 11(13) 1211–1223. https://doi.org/10.1016/j. jcin.2018.02.041 2. Kacila M, Matteucci ML, Bevilacqua S, Granov N, Glauber M. Treatment of left anterior descending artery aneurysm. Bosn J Basic Med Sci. 2006 Nov;6(4):22-4. doi: 10.17305/ bjbms.2006.3113. PMID: 17177643; PMCID: PMC5807962. 3. Sheikh AS, Hailan A, Kinnaird T, Choudhury A, Smith D. Coronary Artery Aneurysm: Evaluation, Prognosis, and Proposed Treatment Strategies. Heart Views. 2019 Jul-Sep;20(3):101-108. doi: 10.4103/HEARTVIEWS. HEARTVIEWS_1_19. PMID: 31620255; PMCID: PMC6791093. 4. Swaye PS, Fisher LD, Litwin P, Vignola PA, Judkins MP, Kemp HG, et al. Aneurysmal coronary artery disease. Circulation. 1983;67:134–8. doi: 10.1161/01.cir.67.1.134. 5. Sushil Kumar Singh, Tushar Goyal, Rishi Sethi, Sharad Chandra, Vijayant Devenraj, Nitin Kumar Rajput, Dinesh Kaushal, Vivek Tewarson, Santosh Gupta, Sarvesh Kumar, Surgical treatment for coronary artery aneurysm: a single-centre experience, Interactive CardioVascular and Thoracic Surgery, Volume 17, Issue 4, October 2013, Pages 632-636, https://doi. org/10.1093/icvts/ivt282 6. Morita H, Ozawa H, Yamazaki S, Yamauchi Y, Tsuji M, Katsumata T, Ishizaka N. A case of giant coronary artery aneurysm with fistulous connection to the pulmonary artery: a case report and review of the literature. Intern Med. 2012;51(11):1361- 6. doi: 10.2169/internalmedicine.51.7134. Epub 2012 Jun 1. PMID: 22687842. 7. Barioli A, Visco E, Pellizzari N, Marzot F, Lanzellotti D, Favero L, Cernetti C. Diagnostic workup and treatment options for aneurysmal coronary artery disease. Vessel Plus. 2024;8:13. http://dx.doi.org/10.20517/2574-1209.2023.68 8. Abou Sherif S, Ozden Tok O, Tas ̧köylü Ö, Goktekin O and Kilic ID (2017) Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and Treatment. Front. Cardiovasc. Med. 4:24. doi: 10.3389/fcvm.2017.00024 9. Chauhan et al.: An unruptured, thrombosed 10 cm right coronary artery aneurysm mimicking a pericardial cyst. Journal of Cardiothoracic Surgery 2013 8:2. 10. Sannino, M.; Nicolai, M.; Infusino, F.; Giulio, L.; Usai, T.L.; Biscotti, G.; Azzarri, A.; De Angelis D’Ossat, M.; Calcagno, S.; Calcagno, S. Coronary Artery Aneurysms: A Clinical Case Report and Literature Review Supporting Therapeutic Choices. J. Clin. Med. 2024, 13, 5348. https://doi.org/10.3390/jcm13185348 11. Pham, V.; Hemptinne, Q.; Grinda, J.; Duboc D.; Varenne, O.; Picard, F. Giant coronary aneurysms, from diagnosis to treatment: A literature review. Archives of Cardiovascular Diseases. 2020, January, 113(1), 59-69. https://doi.org/10.1016/j. acvd.2019.10.008 12. Khouzam, M.S., Khouzam, N. Giant coronary artery aneurysms involving more than one coronary artery: case report. J Cardiothorac Surg 16, 177 (2021). https://doi.org/10.1186/ s13019-021-01560-5. 13. Ramirez, F.D., et. Al. Natural History and Management of Aortocoronary Saphenous Vein Graft Aneurysms. A Systematic Review of Published Cases. American Heart Association. 2012 Oct, (126)18, 1524-4539. 14. Nichols, L., Lagana, S., Parwani, A. Coronary Artery Aneurysm. A Review and Hypothesis Regarding Etiology. Arch Pathol Lab Med (2008) 132 (5): 823–828. https://doi.org/10.5858/2008- 132-823-CAAARA. 15. Bajaj, S. Et Al. Covered-Stent Treatment of Coronary Aneurysm after Drug-Eluting Stent Placement, Case Report and Literature ReviewTex Heart Inst 2010;37(4):449-54). 16. Aoki J, Kirtane A, Leon MB, Dangas G. Coronary artery aneurysms after drug-eluting stent implantation. JACC Cardiovasc Interv. 2008 Feb;1(1):14-21. doi: 10.1016/j. jcin.2007.10.004. PMID: 19393139. 17. Befeler B, Aranda MJ, Embi A, Mullin FL, El-Sherif N, Lazzara R. Coronary artery aneurysms: study of the etiology, clinical course and effect on left ventricular function and prognosis. Am J Med. 1977;62:597-607. 18. Pasha, A.K., Jokerst, C.E., Janardhanan, R. Myocardial Infarction related to a Coronary Artery Aneurysm. The American Journal of Medicine. 2015, February (128)2. http://dx.doi. org/10.1016/j.amjmed.2014.10.017. 19. ElGuindy MS, ElGuindy AM. Aneurysmal coronary artery disease: An overview, Global Cardiology Science and Practice 2017:26. http://dx.doi.org/10.21542/gcsp.2017.26. 20. Khubber S, Chana R, Meenakshisundaram C, et al. Coronary artery aneurysms: outcomes following medical, pinterventional and surgical management. Open Heart 2021;8:e001440. doi:10.1136/openhrt-2020-001440. 21. Sugiyama, K., Matsuyama, K., Maruno, K. et al. A case of ruptured infective coronary artery aneurysm. surg case rep 3, 75 (2017). https://doi.org/10.1186/s40792-017-0347-6. 22. Johnson, P.T., Fishman, E.K. CT Angiography of Coronary Artery Aneurysms; Detection, definition, causes, and treatment. American Journal of Roentology. 2010, March (195)4. https:// doi.org/10.2214/AJR.09.3517. 23. Kacila M, Matteucci ML, Bevilacqua S, Granov N, Glauber M. Treatment of left anterior descending artery aneurysm. Bosn J Basic Med Sci. 2006 Nov;6(4):22-4. doi: 10.17305/ bjbms.2006.3113. PMID: 17177643; PMCID: PMC5807962. 24. Beyer, M., Shoap, S., Beyer, E. Massive Giant Coronary Aneurysm. Annals of Thoracic Surgery. 2024, March (2)1, 38-39. https:// doi.org/10.1016/j.atssr.2023.09.001. 25. Hannah, E.L., Et Al. Circulation: Cardiovascular Interventions. American Heart Association.2022,June(15)6. https://www.ahajournals.org/doi/suppl/10.1161/ CIRCINTERVENTIONS.121.011687. 26. Zhu Et. Al., Challenges and strategies in the management of coronary artery aneurysms. Hellenic Journal of Cardiology 62 (2021) 112-120. https://doi.org/10.1016/j.hjc.2020.09.004. 27. Krüger D, Stierle U, Herrmann G, Simon R, Sheikhzadeh A. Exercise-induced myocardial ischemia in isolated coronary artery ectasias and aneurysms (“dilated coronopathy”). J Am Coll Cardiol. 1999 Nov 1;34(5):1461-70. doi: 10.1016/s0735- 1097(99)00375-7. PMID: 10551693. 28. Gundoğdu F, Arslan S, Buyukkaya E, Senocak H. Treatment of a coronary artery aneurysm by use of a covered stent graft - a case report. Int J Angiol. 2007 Spring;16(1):31-2. doi: 10.1055/ s-0031-1278242. PMID: 22477247; PMCID: PMC2733002. 29. Shah, S, Patel, T, Patel, G. et al. Percutaneous Treatment of Long Coronary Aneurysms: Novel Technique for Increased Efficacy and Safety. J Am Coll Cardiol Case Rep. 2019 Dec, 1 (4) 628–632. https://doi.org/10.1016/j.jaccas.2019.10.004. 30. Deibele AJ, Jennings LK, Tcheng JE, Neva C, Earhart AD, Gibson CM. Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: the Intracoronary Eptifibatide (ICE) Trial. Circulation. 2010 Feb 16;121(6):784- 91. doi: 10.1161/CIRCULATIONAHA.109.882746. 31. Kumar, V. Et. Al. Large intracoronary thrombus and its management during primary PCI. Indian Heart Journal. 72 (2020) 508-516. https://doi.org/10.1016/j.ihj.2020.11.009. 32. Gülec S, Aras O, Atmaca Y, Akyürek O, Hanson NQ, Sayin T, Tsai MY, Akar N, Oral D. Deletion polymorphism of the angiotensin I converting enzyme gene is a potent risk factor for coronary artery ectasia. Heart. 2003 Feb;89(2):213-4. doi: 10.1136/ heart.89.2.213. PMID: 12527685; PMCID: PMC1767548. 33. Zhu L, Cui Q, Liu Y, Liu Z, Zhang Y, Liu F, Wang J. Effects of a Secondary Prevention Combination Therapy with betaBlocker and Statin on Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients. Med Sci Monit. 2020 Aug 18;26:e925114. doi: 10.12659/MSM.925114. PMID: 32808600; PMCID: PMC7453752. 34. Gebbers JO. Atherosclerosis, cholesterol, nutrition, and statins- -a critical review. Ger Med Sci. 2007 Aug 16;5:Doc04. PMID: 19675712; PMCID: PMC2703237. 35. Hedblad B, Wikstrand J, Janzon L, Wedel H, Berglund G. Lowdose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation. 2001 Apr 3;103(13):1721-6. doi: 10.1161/01.cir.103.13.1721. PMID: 11282901. 36. Hu M, Hu S, Gao X, Yang Y. Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era. Medicina (Kaunas). 2022 Aug 30;58(9):1177. doi: 10.3390/medicina58091177. PMID: 36143854; PMCID: PMC9506114. 37. Khalid, N., Kumar, S., Muskula, P., Muhammad, M., Helmy T. Coronary Artery Aneurysms and Acute Coronary Syndrome: An Interventonalist’s Dilemma. Methodist DeBakey Cardiovasc J. 2024;20(1):33-39. doi. 10.14797/mdcvj.1343. 38. Baman TS, Cole JH, Devireddy CM, Sperling LS. Risk factors and outcomes in patients with coronary artery aneurysms. Am J Cardiol. 2004 Jun 15;93(12):1549-51. doi: 10.1016/j. amjcard.2004.03.011. PMID: 15194034. 39. Bararu-Bojan, I., Badulescu, O.-V., Badescu, M. C., Vladeanu, M. C., Plesoianu, C. E., Bojan, A., Iliescu-Halitchi, D., Tudor, R., Huzum, B., Frasinariua, O. E., &amp; Ciocoiu, M. (2024). New Insights into the Pathophysiology of Coronary Artery Aneurysms. Diagnostics, 14(19), 2167. https://doi.org/10.3390/diagnostics14192167. 40. Ovalı C, Morrad B. Associations between coronary artery disease, aneurysm and ectasia. Kardiochir Torakochirurgia Pol. 2017 Sep;14(3):158-163. doi: 10.5114/kitp.2017.70276. Epub 2017 Sep 30. PMID: 29181042; PMCID: PMC5701588. 41. Demopoulos VP, Olympios CD, Fakiolas CN, Pissimissis EG, Economides NM, Adamopoulou E, Foussas SG, Cokkinos DV. The natural history of aneurysmal coronary artery disease. Heart. 1997 Aug;78(2):136-41. doi: 10.1136/hrt.78.2.136. PMID: 9326986; PMCID: PMC484892. 42. Thangathurai J, Kalashnikova M, Takahashi M, Shinbane JS. Coronary Artery Aneurysm in Kawasaki Disease: Coronary CT Angiography through the Lens of Pathophysiology and Differential Diagnosis. Radiol Cardiothorac Imaging. 2021 Oct 28;3(5):e200550. doi: 10.1148/ryct.2021200550. PMID: 34778780; PMCID: PMC8581589. 43. Van Stijn D, Korbee JM, Netea SA, de Winter VC, Zwinderman KAH, Kuipers IM, Kuijpers TW. Treatment and Coronary Artery Aneurysm Formation in Kawasaki Disease: A Per-Day Risk Analysis. J Pediatr. 2022 Apr;243:167-172.e1. doi: 10.1016/j. jpeds.2021.12.054. Epub 2021 Dec 27. PMID: 34968497. 44. Senzaki H. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child. 2006 Oct;91(10):847-51. doi: 10.1136/ adc.2005.087437. PMID: 16990356; PMCID: PMC2066006. 45. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse. 46. Kevin G. Friedman, MD, Kimberly Gauvreau, ScD, Akiko Hamaoka‐Okamoto, MD, Alexander Tang, BS, Erika Berry, MS, Adriana H. Tremoulet, MD, MAS, Vidya S. Mahavadi, MD, Annette Baker, MSN, PNP, Sarah D. deFerranti, MD, David R. Fulton, MD, Jane C. Burns, MD, and Jane W. Newburger, MD, MPH Pruthi S, Bangalore S. The State of Coronary Thrombus Aspiration. J Am Heart Assoc. 2022 Aug 16;11(16):e026849. doi: 10.1161/JAHA.122.026849. Epub 2022 Aug 10. PMID: 35946445; PMCID: PMC9496285. 47. Jolly SS, James S, Džavík V, Cairns JA, Mahmoud KD, Zijlstra F, Yusuf S, Olivecrona GK, Renlund H, Gao P, Lagerqvist B, Alazzoni A, Kedev S, Stankovic G, Meeks B, Frøbert O. Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration. Circulation. 2017 Jan 10;135(2):143-152. doi: 10.1161/CIRCULATIONAHA.116.025371. Epub 2016 Dec 9. PMID: 279410